Prof. Geoffrey Liu, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
Host:Prof. Fang Wu, The Second Xiangya Hospital of Central South University, China
Prof. Liu discussed whether brain-penetrant ALK TKIs can help prevent brain metastases in advanced ALK-positive NSCLC. He also explored how this may shift treatment goals toward high-quality long-term survival and a possible redefinition of clinical cure.